Cooper C. Collins's Insider Trades & SAST Disclosures
Cooper C. Collins's most recent trade in TherapeuticsMD Inc was a trade of 8,500 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cooper C. Collins.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | Cooper C. Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 60,516 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 22 Aug 2024 | 4,094 | 52,016 (0%) | 0% | 1.7 | 7,099 | Common Stock |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 21 Aug 2024 | 1,200 | 47,922 (0%) | 0% | 1.7 | 2,039 | Common Stock |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 8,500 | 8,500 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 46,722 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 18 Nov 2021 | 1,000,000 | 2,236,864 (0%) | 0% | 0.6 | 578,500 | Common Stock |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 17 Aug 2021 | 900,000 | 1,236,864 (0%) | 0% | 0.7 | 648,000 | Common Stock |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 17 Aug 2021 | 100,000 | 336,864 (0%) | 0% | 0.8 | 77,000 | Common Stock |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 236,864 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 99,174 | 99,174 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 96,864 | 96,864 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 08 Jun 2020 | 47,500 | 140,000 (0%) | 0% | 1.5 | 68,875 | Common Stock |
| TherapeuticsMD Inc | Cooper C. Collins | Director | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 08 Jun 2020 | 26,500 | 92,500 (0%) | 0% | 1.5 | 38,425 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges